Ibex Galen (Ibex Prostate Detect)
Save to shortlistLast reviewed Oct 31, 2026 against the sources listed on this page · How we review
At a glance
Ibex Medical Analytics' Galen platform is a clinical-grade AI cancer diagnostics suite for prostate, breast, and gastric biopsies that acts as an AI 'second read' to flag suspicious foci and…
- FDA:
- 510(k) K241232
- Epic:
- Not on record
- Named users:
- 1 named in public reports
- Published study:
- Not on record
Description
Ibex Medical Analytics' Galen platform is a clinical-grade AI cancer diagnostics suite for prostate, breast, and gastric biopsies that acts as an AI 'second read' to flag suspicious foci and reduce missed cancers. Ibex Prostate Detect received FDA 510(k) clearance in February 2025, supported by validation showing a 99.6% positive predictive value and detection of 13% of cancers initially missed by pathologists. The platform is deployed in routine clinical practice across hospital networks and reference laboratories.
Quick answers
Answered only from the sourced records on this page. Questions we can't answer from the record are left out. How we review
- Is Ibex Galen (Ibex Prostate Detect) FDA cleared?
- The public FDA database has one record that our team matched to Ibex Galen (Ibex Prostate Detect). The most recent is 510(k) K241232 (Galen Second Read), decided Jan 2025. Check that the cleared use matches how you plan to use it.FDA record K241232
- Which health systems use Ibex Galen (Ibex Prostate Detect)?
- Linked public reports name one organization: Alverno Laboratories. "Who's using this" below lists them all, plus any the maker reports. Ask the vendor for a reference at an organization like yours.Alverno Laboratories (Northwest Indiana Business Magazine)
Security & contracting
The maker has not reported these details yet. Ask the vendor directly during evaluation.
- Workflow stage
- Not reported
- Integrations
- Not reported
- Data inputs
- Not reported
- Deployment
- Not reported
- Signs a BAA
- Not reported
- SOC 2 report
- Not reported
- HITRUST
- Not reported
- Evidence type
- Not assessed
Readiness details are self-reported by the maker and are not checked by Clinical Intelligence Foundry. Evidence type describes the kind of study or document the listing links to; it is not a rating or endorsement. Confirm compliance documents with the vendor before purchase.
Who's using this
6 organizationsOrganizations named in public announcements or by the developer. Inclusion is not an endorsement.
Reported by the developer
Last checked Oct 31, 2026. Spot an error? Let us know through the discussion below.
Get weekly updates for Pathology
Up to 5 new items a week: new tools, FDA decisions and studies. Newest first, never ranked. Confirm by email, unsubscribe any time.
Sources
This listing links to primary sources. Follow the links below to check details directly with the developer, regulator or publication.
WebsiteFDA database records
- K241232 · 510(k) · Jan 2025Galen Second Read
Matched by our team from the public FDA database; checked Nov 10, 2026.
History (3)Show
Dated events on this listing's public record, newest first.
Developer
Ibex Medical Analytics
Ibex Medical Analytics Ltd. (Tel Aviv, Israel)
Evaluating this tool?
Get a printable packet for your committee: what the public record shows, the gaps to raise with the vendor, and the questions for this kind of tool.
Prepare evaluation packetChecklist for your role: Admin · Physician · IT · Compliance
Compare similar tools →